PRESS RELEASE published on 11/04/2025 at 07:00, 10 months 19 days ago Valneva Reports Positive Results for Phase 1 Trial of Second-Generation Zika Vaccine Candidate Valneva SE reports positive Phase 1 trial results for VLA1601, its second-generation Zika vaccine candidate, showing improved immune response. Safety and immunogenicity demonstrated in trial Phase 1 Trial Valneva SE Safety Immunogenicity Zika Vaccine
BRIEF published on 10/09/2025 at 16:04, 11 months 13 days ago Bpifrance Crosses Threshold in the Capital of Valneva SE Stock Market Valneva SE Threshold Crossing Bpifrance Deposit Fund
BRIEF published on 10/09/2025 at 16:04, 11 months 13 days ago Franchissement de Seuil par Bpifrance dans le Capital de Valneva SE Franchissement De Seuil Valneva SE Bpifrance Caisse Des Dépôts Marché Actions
PRESS RELEASE published on 10/09/2025 at 15:59, 11 months 13 days ago Franchissement de seuil Déclaration de franchissement de seuil de Bpifrance Participations SA pour VALNEVA SE et CDC, détenant respectivement 4,92% et 7,63% du capital de la société Déclaration Franchissement De Seuil Valneva SE CDC Bpifrance Participations SA
BRIEF published on 10/06/2025 at 07:35, 11 months 17 days ago Valneva Updates on Shares and Voting Rights Voting Rights Shares Euronext Valneva France
BRIEF published on 10/06/2025 at 07:35, 11 months 17 days ago Valneva fait le point sur ses actions et ses droits de vote Euronext Actions Droit De Vote Valneva France
PRESS RELEASE published on 10/06/2025 at 07:30, 11 months 17 days ago VALNEVA Déclaration d’actions et de droits de vote : 30 septembre 2025 VALNEVA fait une déclaration d'actions et de droits de vote, incluant des changements au porteur et en double droit de vote. Informations du 30 septembre 2025 Déclaration Droits De Vote Actions Valneva 30 Septembre 2025
PRESS RELEASE published on 10/06/2025 at 07:30, 11 months 17 days ago VALNEVA Declaration of shares and voting rights: September 30, 2025 Valneva declares transfer into bearer form of 653 shares with double voting rights and grants double voting rights on 100 ordinary shares, affecting total voting rights Voting Rights Valneva Shares Transfer Double Rights Bearer Form
BRIEF published on 09/03/2025 at 07:05, 1 year ago Progrès significatifs pour le vaccin contre la maladie de Lyme de Valneva Valneva Phase 2 Vaccin Lyme Immunogénicité Innocuité
BRIEF published on 09/03/2025 at 07:05, 1 year ago Valneva's Lyme Disease Vaccine Makes Significant Progress Valneva Safety Phase 2 Lyme Vaccine Immunogenicity
Published on 09/23/2026 at 14:31, 31 minutes ago First Breach Completes First Untethered Flight of Proprietary Drone Prototype, Advancing American-Made Unmanned Systems Program
Published on 09/23/2026 at 14:30, 32 minutes ago Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox (MPox) Has Begun in DRC, Announces NanoViricides
Published on 09/23/2026 at 14:00, 1 hour 2 minutes ago Integrated Rewards Launches "Celebrate Canadian" Campaign to Connect Canadian Brands with Millions of Consumers
Published on 09/23/2026 at 13:30, 1 hour 32 minutes ago Engineering Cost Study Validates Commercial-Scale U.S. HPMSM Capital Cost and Establishes EMM Capital Cost for Electric Metals' North Star Manganese Project
Published on 09/23/2026 at 13:30, 1 hour 32 minutes ago Green Bridge Metals Corporation Announces Phase 2 Diamond Drill Program at the Titac Titanium-Copper-Vanadium Project, Minnesota, USA
Published on 09/23/2026 at 14:30, 31 minutes ago TCL Solar C2 back-contact panels arrive in Europe, open for order
Published on 09/23/2026 at 14:26, 36 minutes ago Leading Asian advanced semiconductor packaging manufacturer selects LPKF’s glass processing equipment for production ramp-up
Published on 09/23/2026 at 14:25, 36 minutes ago InovCluster: Buyers are heading to Portugal to discover new business opportunities with Portuguese SMEs in the food and drink sector
Published on 09/23/2026 at 14:20, 41 minutes ago vHive Expands Industry-Leading Digitization Platform into the Data Center Market
Published on 09/23/2026 at 14:20, 41 minutes ago Turkiye Garanti Bankasi A.S.: _Redemption of the debt instrument at abroad within the Medium Term Note (MTN) program XS3184157066
Published on 09/23/2026 at 08:00, 7 hours 2 minutes ago Résultats semestriels 2026 - ANR par action : 101,90 €, en progression de 8,18 % - Capitaux propres consolidés : 774,5 M€
Published on 09/22/2026 at 18:00, 21 hours 2 minutes ago Consolidated results for the first half of 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 18:00, 21 hours 2 minutes ago Résultats consolidés du premier semestre 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 17:45, 21 hours 17 minutes ago Imerys-09-2026-information-share-capital-and-voting-rights-as-of-31-August-2026
